Valence 로고
인기
로그인
Loading data for GELS — first visit, this takes a few seconds.

관심목록에 추가

Gelteq Limited

NasdaqCM: GELS · 실시간 가격 · USD
0.58
+0.00 (0.00%)
종가 기준: Aug 14, 2026, 8:00 PM
0.63
+7.78%
프리마켓: 7:36 AM

Gelteq Limited (GELS) Stock Price, Analysis & Data

0.00%

데이터 없음

매수호가n/a
시가총액6.21M
매출 (ttm)471.8K
순이익 (ttm)-7.08M
베타n/a
EPS (ttm)-0.51
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)0.65
P/S (ttm)13.17
Earnings Daten/a
매도호가n/a
거래량26,927
평균 거래량 (20일)3,682,227
시가0.61
전일 종가0.58
일중 범위0.58 - 0.63
52주 범위0.39 - 2.02
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

GELS 소개

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia....

[더 보기]
산업 Drug Manufacturers - Specialty & Generic
섹터 Healthcare
IPO 일자 Oct 29, 2024
직원 수 7
상장 거래소 NasdaqCM
티커 GELS
웹사이트 https://www.gelteq.com
전체 기업 정보

재무 실적

2025년 Gelteq의 매출은 165.65K로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -6.65M로, 87.4% 증가했습니다.

재무제표
news image

7개월 전 · TipRanks

Gelteq announces preclinical results on medicinal cannabinoid absorption

Gelteq (GELS) announced positive results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company’s proprietary oral gel platform. The findings d...

news image

11개월 전 · MT Newswires

Top Midday Gainers

SINTX Technologies (SINT) said Wednesday it published a peer-reviewed study demonstrating that silic